---
category: news
title: "GT Apeiron Announces Enrollment of First Patient in Phase 1/2 \"ELUCIDATE\" Clinical Trial of CDK7 Inhibitor, GTAEXS617, in Advanced Solid Tumors"
excerpt: "Preclinical data from AI-optimized GTAEXS617 support potential for improved therapeutic index compared to other CDK7 inhibitors under development - - Parallel translational initiative to evaluate preclinically identified non-invasive PD biomarkers with potential to predict GTAEXS617 treatment responders - SAN FRANCISCO and SHANGHAI,"
publishedDateTime: 2023-07-10T11:17:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/07/10/9844912.htm"
webUrl: "https://technews.tmcnet.com/news/2023/07/10/9844912.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "L43hR1FED4sFqkD6HCe211WB0SXLf/TJkL9MqdEeZ18k3iYjZUAwLk02kR+dISAdcG+Sd0kiOISxculNIOUFEpoGyAh/um8QGRKQVxVqDfBRr8tqvget9WagLi22j3jkpI9gw6KvHDAfMGFwr2ukd3i9WslfMn2TJNDE7Kp4hLlSIclPiOwGsqDq+rkffr1g2AppIER+0pjLvahiLczACKWDgxf4h9wRZZgSIJiIrfWbD3EbKcGWpncSy0aCdwU66WHsn2gAGYgkdNnsYLqV+b8sat7DZuooo00bP1/HAS+wX1fviwPB4jqH9p6aNwOvRTRO18CISfDClnP712TmR9CKkx73qMVzuiuTQ2x1RrI=;paHgqr3fapFpK6pxcOQufQ=="
---

